The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses

BMC Psychiatry

Louise M Howard⁴  Dharmintra Pasupathy³  Matthew Broadbent¹  Jack Ogden⁴  Robert Stewart²  Clare L Taylor⁴ 

[1] South London and Maudsley NHS Foundation Trust, London, UK;Department of Psychological Medicine, King’s College London, Institute of Psychiatry, London, UK;Women’s Health Academic Centre, King’s College London, London, UK;Section of Women’s Mental Health/Women’s Health Academic Centre, Department of Health Service and Population Research, King’s College London, Institute of Psychiatry, London, UK

关键词: Pregnancy;    Bipolar disorder;    Schizophrenia;   

Others  :  1177234
DOI  :  10.1186/s12888-015-0451-8

 received in 2014-12-18, accepted in 2015-03-19,  发布年份 2015

【 摘 要 】

Background

Most women with psychotic disorders and bipolar disorders have children but their pregnancies are at risk of adverse psychiatric and fetal outcome. The extent of modifiable risk factors – both clinical and socio-demographic – is unclear as most studies have used administrative data or recruited from specialist tertiary referral clinics. We therefore aimed to investigate the socio-demographic and clinical characteristics of an epidemiologically representative cohort of pregnant women with affective and non-affective severe mental illness.

Methods

Women with severe mental illness were identified from a large electronic mental health case register in south London, and a data linkage with national maternity Hospital Episode Statistics identified pregnancies in 2007–2011. Data were extracted using structured fields, text searching and natural language processing applications.

Results

Of 456 pregnant women identified, 236 (51.7%) had schizophrenia and related disorders, 220 (48.3%) had affective psychosis or bipolar disorder. Women with schizophrenia and related disorders were younger, less likely to have a partner in pregnancy, more likely to be black, to smoke or misuse substances and had significantly more time in the two years before pregnancy in acute care (inpatient or intensive home treatment) compared with women with affective disorders. Both groups had high levels of domestic abuse in pregnancy (recorded in 18.9%), were from relatively deprived backgrounds and had impaired functioning measured by the Health of the Nation Outcome Scale. Women in the affective group were more likely to stop medication in the first trimester (39% versus 25%) whereas women with non-affective psychoses were more likely to switch medication.

Conclusions

A significant proportion of women, particularly those with non-affective psychoses, have modifiable risk factors requiring tailored care to optimize pregnancy outcomes. Mental health professionals need to be mindful of the possibility of pregnancy in women of childbearing age and prescribe and address modifiable risk factors accordingly.

【 授权许可】

   
2015 Taylor et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Howard LM, Kumar R, Thornicroft G: Psychosocial characteristics and needs of mothers with psychotic disorders. Br J Psychiatry 2001, 178:427-32.
• [2]Howard LM, Kumar C, Leese M, Thornicroft G: The general fertility rate in women with psychotic disorders. Am J Psy 2002, 159(6):991-7.
• [3]Vigod SN, Seeman MV, Ray JG, Anderson GM, Dennis CL, Grigoriadis S, et al.: Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996–2009): a population-based study in Ontario, Canada. Schizophr Res 2012, 139(1–3):169-75.
• [4]Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al.: Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–2008, the eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG 2011, 118:1-205.
• [5]Austin M, Kildea S, Sullivan E: Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Med J Aus 2007, 186(7):364.
• [6]Howard LM: Fertility and pregnancy in women with psychotic disorders. Eur J Obstet Gynecol Reprod Biol 2005, 119(1):3-10.
• [7]Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I: Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry 2011, 72(7):979-85.
• [8]Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, et al. Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001–2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013: p. 1–9.
• [9]Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al.: Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007, 164(12):1817-24.
• [10]Bodén R, Lundgren M, Brandt L, Reutfors J, Andersen M, Kieler H. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: Population based cohort study. BMJ. 2012. 345.
• [11]Maccabe JH, Martinsson L, Lichtenstein P, Nilsson E, Cnattingius S, Murray RM, et al.: Adverse pregnancy outcomes in mothers with affective psychosis. Bipolar Disorders 2007, 9(3):305-9.
• [12]Webb R, Abel K, Pickles A, Appleby L: Mortality in offspring of parents with psychotic disorders: a critical review and meta-analysis. Am J Psy 2005, 162(6):1045-56.
• [13]Webb RT, Pickles AR, King-Hele SA, Appleby L, Mortensen PB, Abel KM: Parental mental illness and fatal birth defects in a national birth cohort. Psychol Med 2008, 38(10):1495-503.
• [14]McColl H, Dhillon M, Howard LM: A systematic review of the nutritional status of women of a childbearing age with severe mental illness. Arch Womens Ment Health 2013, 16(1):39-46.
• [15]Molyneaux E, Poston L, Ashurst-Williams S, Howard LM: Obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis. Obstetrics Gynecology 2014, 123(4):857-67.
• [16]Howard LM, Oram S, Galley H, Trevillion K, Feder G: Domestic violence and perinatal mental disorders: a systematic review and meta-analysis. PLoS Med 2013, 10(5):e1001452.
• [17]Judd F, Komiti A, Sheehan P, Newman L, Castle D, Everall I: Adverse obstetric and neonatal outcomes in women with severe mental illness: To what extent can they be prevented? Schizophr Res 2014, 157(1):305-9.
• [18]Fernandes AC, Cloete D, Broadbent MT, Hayes RD, Chang CK, Jackson RG, et al.: Development and evaluation of a de-identification procedure for a case register sourced from mental health electronic records. BMC Med Inform Decis Mak 2013, 13:71. BioMed Central Full Text
• [19]Stewart R, Soremekun M, Perera G, Broadbent M, Callard F, Denis M, et al.: The South London and Maudsley NHS foundation trust biomedical research centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry 2009, 9(1):51. BioMed Central Full Text
• [20]Sultana J, Chang C, Hayes R, Broadbent M, Stewart R, Corbett A, et al. Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. Int J Geriatr Psychiatry, 2014.
• [21]Hospital Episode Statistics [http://www.hscic.gov.uk/hes]
• [22]Organization WH. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. 1992.
• [23]Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, et al.: Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf 2013, 22(5):524-32.
• [24]Noble M, Mclennan D, Wilkinson K, Whitworth A, Exley S, Barnes H, et al.: The English indices of deprivation. Communities and Local Government, London; 2007.
• [25]Johnson S, Needle J, Bindman JP, Thornicroft G: Crisis resolution and home treatment in mental health. Cambridge University Press, New York; 2008.
• [26]Wing J, Beevor A, Curtis R, Park S, Hadden S, Burns A: Health of the Nation Outcome Scales (HoNOS), Research and development. Br J Psychiatry 1998, 172(1):11-8.
• [27]Pagel T, Franklin J, Baethge C: Schizoaffective disorder diagnosed according to different diagnostic criteria–systematic literature search and meta-analysis of key clinical characteristics and heterogeneity. J Affect Disord 2014, 156:111-8.
• [28]Smoking in Pregnancy- Southwark data. Health Profiles 2013. http://www.apho.org.uk/resource/view.aspx?RID=126453
• [29]Jahanfar S, Janssen Patricia A, Howard Louise M, Dowswell T. Interventions for preventing or reducing domestic violence against pregnant women. In: Cochrane Database Syst Rev. John Wiley & Sons, Ltd; 2013.
• [30]Habermann F, Fritzsche J, Fuhlbrück F, Wacker E, Allignol A, Weber-Schoendorfer C, et al.: Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 2013, 33(4):453-62.
• [31]Man SL, Petersen I, Thompson M, Nazareth I: Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS One 2012, 7(12):e52339.
• [32]Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al.: Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New Eng J Med 2009, 360(16):1597-605.
• [33]Scottish Intercollegiate Guidelines Network (SIGN): Management of perinatal mood disorders In Vol. (SIGN publication no. 127). SIGN, Edinburgh; 2012:2012.
• [34]National Institute for Health and Clinical Excellence: Antenatal and postnatal mental health: clinical management and service guidance. The British Psychological Society & The Royal College of Psychiatrists, London; 2007.
• [35]Grande I, Bernardo M, Bobes J, Saiz-Ruiz J, Álamo C, Vieta E. Antipsychotic switching in bipolar disorders: a systematic review. Int J Neuropsychopharmacol. 2013:1-11.
• [36]Rosa F, Schreiner A, Thomas P, Sherif T: Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable. Clin Drug Investig 2012, 32(4):267-79.
• [37]Roussidis A, Kalkavoura C, Dimelis D, Theodorou A, Ioannidou I, Mellos E, et al.: Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study. Annals General Psy 2013, 12(1):42. BioMed Central Full Text
• [38]Newport DJ, Stowe ZN, Viguera AC, Calamaras MR, Juric S, Knight B, et al.: Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord 2008, 10(3):432-6.
• [39]Murray J, Saxena S, Modi N, Majeed A, Aylin P, Bottle A. Quality of routine hospital birth records and the feasibility of their use for creating birth cohorts. J Public Health 2012.
• [40]Births in England and Wales by Characteristics of Birth 2, 2011 http://www.ons.gov.uk/ons/dcp171778_298892.pdf.